India has emerged as a global hub for pharmaceutical manufacturing and innovation, particularly in the cardiovascular segment. Cardiovascular diseases (CVDs) are among the leading causes of mortality worldwide, and Indian pharmaceutical companies play a critical role in providing effective and affordable solutions for these conditions.
